Analysts think CRBP stock price could increase by 265%
Dec 04, 2024, 12:26 PM
-29.55%
What does CRBP do
Corbus Pharmaceuticals, based in Norwood, Massachusetts, focuses on developing therapies for rare inflammatory diseases and cancer, with a pipeline including CRB-701 and CRB-601. The company went public on October 24, 2014, and employs 19 staff.
11 analysts think CRBP stock price will increase by 265.37%. The current median analyst target is $61.20 compared to a current stock price of $16.75. The lowest analysts target is $35.35 and the highest analyst target is $78.75.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
